Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of MDMA on Prefrontal and Amygdala Activation in Posttraumatic Stress Disorder

NCT03752918 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT03752918
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03752918 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of MDMA on Prefrontal and Amygdala Activation in Posttraumatic Stress Disorder
Lead sponsor
Yale University
Phase
Phase 1
Overall status
Withdrawn
Start date
May 31, 2024
Completion date
January 31, 2028
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post traumatic stress disorder